Jorge A. Quiroz
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Jorge A. Quiroz
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
33
| Subsidiary | Pharmaceuticals: Major | 33 |
| Public Company | Biotechnology | 10 | |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jorge A. Quiroz via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Director/Board Member | |
| AMYRIS, INC. | Chemicals: Specialty | Director/Board Member Chairman | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member | |
| Imperial College London | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Undergraduate Degree | |
| Princeton University | College/University | Doctorate Degree Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree | |
| University of Zurich | College/University | Undergraduate Degree Doctorate Degree | |
| University of Bern | College/University | Doctorate Degree Undergraduate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin | |
| SPEXIS AG | Pharmaceuticals: Major | Director/Board Member | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Investment Managers | Private Equity Investor | |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Founder Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
Calico LLC
 Calico LLC BiotechnologyHealth Technology Part of Alphabet, Inc., Calico LLC conducts research into the biology of aging. The company is based in South San Francisco, CA. Arthur D. Levinson has been the CEO of the company since 2013. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Amal Therapeutics SA
 Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member | |
Raziel Therapeutics RT Ltd.
 Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Enterprise Therapeutics Ltd.
 Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Enterprise Therapeutics Ltd. operates as a drug discovery company that engages in the research and development of therapies for the treatment of respiratory diseases. It focuses on developing therapies for chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company was founded by John Mervyn David Store in May 2014 and is headquartered in Falmer, the United Kingdom. | Biotechnology | Director/Board Member | |
| MSH Medical School Hamburg GmbH | College/University | Doctorate Degree | |
| Versant Ventures (Switzerland) GmbH | Investment Managers | Private Equity Investor Private Equity Analyst | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Bayer GmbH
 Bayer GmbH Engineering & ConstructionIndustrial Services Bayer GmbH specializes in providing consulting, planning, and installation services for fencing systems, gates, and barriers for both private and industrial sectors. The private company is based in Leverkusen, Germany. | Engineering & Construction | Corporate Officer/Principal | |
Azafaros BV
 Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
TOLREMO therapeutics AG
 TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Volastra Therapeutics, Inc.
 Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
| Ridgeline Therapeutics | Chief Tech/Sci/R&D Officer | ||
| Swiss Rockets AG | Chief Operating Officer | ||
| Amedix GmbH | Founder |
Statistieken
Internationaal
| Verenigde Staten | 26 |
| Zwitserland | 16 |
| Verenigd Koninkrijk | 4 |
| Duitsland | 4 |
| Nederland | 3 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Finance | 4 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 216 |
| Corporate Officer/Principal | 136 |
| Independent Dir/Board Member | 66 |
| Chief Tech/Sci/R&D Officer | 58 |
| Chairman | 38 |
Sterkste connecties
| Insiders | |
|---|---|
| Luba Greenwood | 32 |
| Patrick Yang | 28 |
| William Burns | 27 |
| Adam Koppel | 26 |
| Roland Diggelmann | 22 |
| Zafrira Avnur | 20 |
| Harlan Weisman | 20 |
| Arthur Levinson | 19 |
| Hyam Levitsky | 18 |
| Alexander Mayweg | 18 |
| Karen Wagner | 17 |
| Hal Barron | 16 |
| Raj Shah | 16 |
| Sukumar Nagendran | 15 |
| Bruno Gehrig | 15 |
- Beurs
- Insiders
- Jorge A. Quiroz
- Bedrijfsconnecties
